Media
Investors
Careers
About Roche
About Roche
Strategy
Business
Sustainability
Leadership
Governance
History
Solutions
Solutions
Focus areas
Pharma solutions
Diagnostics solutions
Pipeline
Innovation
Innovation
Team & structure
Innovation process
Ethical standards
Partnering
Stories
Roche Venture Fund
Roche Venture Fund News Archive
GlycoEra AG announced today the close of a CHF 45 million ($49 million) Series A financing round
Entrada Therapeutics Announces Closing of Intitial Public Offering
Jasper Therapeutics Closes Transaction With Amplitude Healthcare Creating a Publicly Traded Biotechnology Company
Tango Therapeutics, Inc.closes merger with BCTG Acquisition Corp
Tempest Closes Merger with Millendo and Completes PIPE Financing
23andMe Successfully Closes its Business Combination with VG Acquisition Corp.
Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
Soteria Biotherapeutics launches with USD42 Million Series A Financing led by Roche Venture Fund and 5AM Ventures
Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
Merck Completes Acquisition of Pandion Therapeutics
Enthera Pharmaceuticals extends Series A financing, raising a total of €35 million
Enliven Therapeutics Launches With Vision Of Advancing Medicine And Restoring Lives
Aligos Therapeutics announces Pricing of Initial Public Offering
C4 Therapeutics announces Pricing of an Upsized Initial Public Offering
Palladio Biosciences completes USD20 Million Series B Financing
BCTG Acquisition Corp. Announces Pricing of Upsized $145 Million Initial Public Offering
Vaxcyte Announces Pricing of Upsized Initial Public Offering
Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use
Jasper Therapeutics Announces Expansion of Series A Financing, Bringing Total Corporate Fundraising to More than $50 Million
Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy
Black Diamond Therapeutics Closes $85 Million Series C Financing
NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
Allakos Announces AK002 Met All Prespecified Primary and Secondary Endpoints in Phase 2 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE)
Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection
Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform
IDEAYA Announces Pricing of Initial Public Offering
Arch Oncology Raises $50 Million Series B Financing
Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform
Tempest and Millendo Announce Proposed Merger Agreement
Allakos announces Pricing of Initial Public Offering
Roche joins Intel & iSeed as investors in Care Innovations to expand its integrated diabetes management solutions with mySugr
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing. Inkef Capital and Roche Venture Fund join investor syndicate
IDEAYA Biosciences Raises $94 Million Crossover Series B Financing
Pandion Therapeutics Announces $58 Million Series A Financing to Advance Tissue-Specific Immune Modulator Drugs for Autoimmune and Inflammatory Diseases
Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology
Roche to acquire Viewics, Inc. to provide data-driven lab business analytics and add further digital capabilities along the laboratory value chain
mySugr joins the Roche Family
Aileron Therapeutics Announces Pricing of Initial Public Offering
Senseonics Announces Pricing of $41 Million Underwritten Offering of Common Stock
Vivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases
CiVi Biopharma Receives Worldwide Exclusive License to Develop a Novel, RNA Targeted Drug Against PCSK-9
Tioma Therapeutics Announces $86 Million Series A Financing
Viewics Secures $10.5 Million in Capital, Closes Funding to Bring Advanced Analytics to Healthcare
Omicia Raises $23 Million in Series B Funding
Purigen Biosystems Receives $18.2M in Series A Financing led by 5AM Ventures and Roche Venture Fund
Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund
Lumos Pharma raises $34 million in Series B financing
News archive